Vilya Company
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Industry:
Early Drug Development
Headquarters:
Seattle, Washington, United States
Founded Date:
2022-01-01
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
50000000
Last Funding Date:
2022-08-29
Last Funding Type:
Series A
Register and Claim Ownership